21 May 2012 07:00
For Immediate Release | 21 May 2012 |
Sphere Medical Holding plc
Grant of Share Options and Directors' Interests
Cambridge, UK, 21 May, 2012: Sphere Medical Holding plc (AIM: SPHR.L) (the "Company"), a leading developer of innovative monitoring and diagnostic products for the critical care setting, received notification on 18 May 2012 that the following Non-Executive Directors acquired ordinary shares in the Company as set out below:
Name | Dealing Date | Number of Ordinary Shares Acquired | Price Paid per Ordinary Share | Total Resulting Interest over Ordinary Shares | Total Resulting Interest over Ordinary Shares % of the Issued Share Capital |
Anthony Martin | 18/5/12 | 20,000 | 79p | 178,931 | 0.49% |
John Gregory | 18/5/12 | 12,500 | 79p | 34,121 | 0.09% |
Stephen Mahle | 18/5/12 | 15,000 | 79p | 45,996 | 0.13% |
For further information, please contact:
Sphere Medical Holding plc | Tel: +44 (0)1223 875222 |
Dr Stuart Hendry, Chief Executive Officer | |
Matthew Hall, Chief Financial Officer | |
Peel Hunt LLP | Tel: +44 (0) 20 7418 8900 |
James Steel | |
Dr Vijay Barathan | |
Buchanan | Tel: +44 (0) 20 7466 5000 |
Tim Anderson Jessica Fontaine | |
www.spheremedical.com |
Notes for Editors
Sphere Medical commenced trading on the AIM, a market operated by the London Stock Exchange (LSE), on 17 November 2011 having raised £14m (£12.8m net of expenses) in a placing of ordinary shares.
Sphere Medical is a UK based medical device company completing the development of a range of monitoring and diagnostic products designed to provide significant improvements in patient management in a number of hospital specialities. Sphere Medical's products are expected to allow near real time measurement of blood gases, various electrolytes and drug levels with laboratory accuracy, at the patient's bedside. This information can be used in a wide range of medical applications and is intended to enable faster clinical decision making and consequently to improve the management of patients.